Skip to main content
Clinical Trials/NCT03224845
NCT03224845
Recruiting
N/A

Transgenerational Prevention of Anxiety in Children at Ultra-high Risk

Nova Scotia Health Authority1 site in 1 country88 target enrollmentSeptember 17, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Anxiety Disorder
Sponsor
Nova Scotia Health Authority
Enrollment
88
Locations
1
Primary Endpoint
Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Anxiety disorders usually start in childhood and adolescence and are associated with social and occupational difficulties in adulthood. Children who have a parent with an anxiety disorder and who find new situations distressing and avoid them are at an increased risk for developing an anxiety disorder. Research suggests that anti-anxiety parenting can help children grow up courageous and calm. It is, however, difficult to parent in an anti-anxiety way when the parent has an anxiety disorder himself or herself.

This research study will test the efficacy of a new program designed to prevent the onset or persistence of anxiety disorders in children at risk for anxiety disorders. The investigators will first help parents learn skills to cope with their own anxiety and then coach them to share these skills with their children and parent in an anti-anxiety way. The goal is to intervene early enough in the children's lives so that they can be free of anxiety disorders and lead happy, healthy and productive lives in adulthood.

Registry
clinicaltrials.gov
Start Date
September 17, 2017
End Date
September 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)

Time Frame: Ten years post randomization

Diagnosis of anxiety disorder in the offspring

Secondary Outcomes

  • Global Assessment of Functioning(Ten years post randomization)
  • Screen for Child Anxiety Related Disorders(Ten years post randomization)
  • Structured Clinical Interview for DSM-5 diagnoses (SCID-5)(Two years post randomization)
  • Laboratory Temperament Assessment Battery(Two years post randomization)
  • Teaching Task Battery(Two years post randomization)
  • Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)(Ten years post randomization)
  • Spence Children's Anxiety Scale(Five years post randomization)

Study Sites (1)

Loading locations...

Similar Trials